MRC, GSK and UK Uni’s Collab for Inflammatory Diseases Drug Development

GlaxoSmithKline (GSK) and the UK’s Medical Research Council (MRC) will be collaborating in an open innovation research initiative aiming to improve scientists’ understanding of inflammatory diseases. The Experimental Medicine Initiative to Explore New Therapies (EMINENT) network will bring together researchers from the Universities of Cambridge, Glasgow, Newcastle, Imperial College London and UCL, with GSK scientists

Continue Reading

GSK Invests £25 Million into their Montrose, Scotland Facility

GSK Invests £25 Million into their Montrose, Scotland FacilityGlaxoSmithKline (GSK) have announced that they will invest £25 million to bring production of ingredients for four new pharmaceutical products to their site in Montrose, Scotland. The investment is expected to create 25 new jobs for process technicians, engineers and chemists, increasing the total GlaxoSmithKline workforce in

Continue Reading

GlaxoSmithKline Announce Q1 Results

Pharmaceutical drug maker, GlaxoSmithKline (GSK), today announced that their revenue increased just 1% in the first quarter, reflecting burdens on the organisation from government price cuts in Europe and some emerging markets, and hard year-by-year comparisons. GSK’s results were boosted by the sale of U.S. rights to a bladder drug, which added approximately £170 million

Continue Reading